Ocular Therapeutix Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +7.1% | -7.0% | -7.8% | +19.4% | -6.9% | -30.2% | +90.6% | -23.1% | +1.2% | -2.4% | +32.1% | +27.5% | +172.1% | +15.6% | -39.9% | +274.5% | +25.1% | -0.1% | +59.6% | +3.7% | +1.3% | +7.1% | -7.0% | -2.5% | +17.6% | -5.0% | +13.5% | -0.7% | -1.9% | -0.2% | +11.3% | -6.2% | +10.7% | -37.4% | +25.8% | +8.1% | -8.9% | -18.6% | +24.9% | – | |
| – | +13.4% | -9.4% | -9.6% | +20.2% | -9.6% | -29.2% | +91.3% | -24.8% | +1.7% | +9.4% | +331.3% | +46.0% | +4.1% | -2.4% | -83.6% | +235.8% | +51.1% | +31.2% | +22.9% | +19.5% | -15.4% | +17.3% | -11.2% | -7.1% | -5.7% | +20.0% | +7.4% | +5.6% | +0.7% | -4.3% | +13.8% | +3.4% | -21.2% | +2.6% | +54.0% | -8.7% | -10.1% | -16.6% | +51.3% | – | |
| – | +5.2% | -6.3% | -7.2% | +19.2% | -6.0% | -30.5% | +90.4% | -22.6% | +1.0% | -5.9% | -73.1% | -76.5% | +6,060.9% | +26.3% | -19.8% | +278.1% | +22.9% | -3.3% | +64.7% | +2.1% | +3.3% | +6.1% | -6.5% | -2.0% | +19.9% | -6.9% | +14.2% | -1.3% | -2.1% | +0.2% | +11.0% | -7.2% | +14.3% | -40.5% | +22.0% | +10.9% | -8.7% | -18.9% | +21.2% | – | |
| – | +28.9% | -8.2% | +20.6% | +0.1% | -2.7% | +4.0% | +6.3% | +10.7% | +5.9% | +10.3% | -16.8% | +8.7% | -1.1% | -39.8% | +31.5% | -13.3% | +9.7% | +43.3% | +26.8% | -8.2% | -1.1% | +4.2% | +0.0% | +4.7% | -1.3% | +8.9% | +2.4% | -0.5% | +7.8% | +28.0% | +39.2% | +28.4% | +10.6% | +4.6% | +19.2% | +2.5% | -3.0% | +30.3% | -18.2% | – | |
| – | +14.4% | +9.1% | +13.7% | +13.6% | +1.2% | +11.5% | -6.8% | +0.0% | +15.2% | +4.6% | -5.6% | +21.7% | -9.8% | -6.8% | -0.6% | +15.9% | +10.3% | +16.5% | +12.2% | -6.1% | -6.7% | +0.3% | +3.0% | +9.6% | -2.1% | +124.8% | -56.3% | +105.9% | +159.0% | -47.3% | -14.7% | -37.8% | +97.1% | +20.0% | -8.2% | -39.7% | +10.2% | +13.3% | +10.8% | – | |
| – | +33.9% | +24.7% | +16.5% | -16.5% | -16.1% | +4.8% | +2.5% | +8.1% | +16.3% | +13.3% | +8.4% | +6.8% | -1.5% | -19.3% | +5.0% | +0.6% | +8.1% | +27.0% | +15.6% | -1.6% | -3.7% | +1.6% | +4.4% | +4.5% | 0.0% | +7.0% | -0.7% | -4.5% | +1.7% | +34.7% | +29.9% | +2.3% | +11.0% | +10.4% | +7.9% | +2.9% | -0.1% | +26.3% | -9.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -1.9% | +6.0% | +5.6% | +4.9% | -0.2% | -0.8% | -6.4% | -6.8% | -11.8% | +172.2% | +59.8% | +1.5% | +9.3% | -9.5% | +3.7% | +1.2% | +0.6% | -2.7% | -1.4% | +0.2% | +1.3% | +0.2% | +0.8% | +6.0% | +2.8% | -4.3% | +12.6% | +72.1% | +21.2% | -2.4% | -21.1% | +0.9% | -3.7% | -3.9% | +1.1% | -0.5% | -5.7% | -1.9% | +0.5% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -371.7% | – | -244.9% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -143.5% | – | +22.8% | +338.9% | -185.5% | – | +22.2% | +7.0% | -240.9% | – | +59.8% | +1.0% | -31.2% | +44.4% | +3.7% | +1.2% | -38.3% | +58.7% | -1.4% | +0.1% | +1.3% | -414.9% | – | – | -244.4% | – | -67.3% | -144.7% | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -371.7% | – | -244.9% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -214.1% | – | -132.6% | – | – | – | – | – | – | – | -734.5% | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.